TRT for perimenopause: what 3 months of testosterone actually does

What did @theneondaisyllc_ actually say?

Here's the awkward truth: the transcript doesn't contain a single spoken claim. The audio is song lyrics, not a personal testimonial. The actual claims live entirely in the caption, where the creator says TRT has been "a complete life changer" after 10-plus months of perimenopause symptoms, describes herself as "a walking zombie," and credits a doctor who listens to her for turning things around in three months. That's what we're actually fact-checking here.

That distinction matters. A caption is not a medical explanation. It's a personal endorsement with zero clinical detail, no mention of dosage, no lab values, no symptom specifics beyond exhaustion. Emotional testimonials can be completely genuine and still tell us almost nothing useful about whether TRT will work for someone else in perimenopause.

Does the science back this up?

The short answer is: partially, and with significant caveats. Testosterone does decline in women during perimenopause, and there is legitimate clinical interest in low-dose testosterone for women, but the evidence base is nowhere near as settled as it is for men.

A 2019 global position statement published in The Journal of Clinical Endocrinology and Metabolism (Davis et al.) reviewed data from over 8,000 women and concluded that testosterone therapy has the best evidence for improving sexual dysfunction in postmenopausal women. The data on fatigue, cognitive fog, and mood, which are the symptoms implied by "walking zombie," is far murkier. A 2021 review in Climacteric (Islam et al.) noted that while women report subjective improvements in energy and wellbeing on testosterone, randomized controlled trial data for these non-sexual outcomes remains limited. The FDA has not approved any testosterone product specifically for women in the United States, which means any prescription is off-label. That doesn't make it wrong, but it does mean patients should ask hard questions.

What did they get wrong (or right)?

They didn't get much factually wrong, because they didn't make many factual claims. What they got right is that perimenopause is genuinely underdiagnosed and undertreated. Research published in Menopause (Shifren et al., 2008) found that a substantial proportion of women experience significant quality-of-life disruption during perimenopause that goes unaddressed in primary care. The frustration of suffering for "10+ months" before getting help is a real and documented problem, not drama.

Where the caption oversimplifies is in the implied causal chain: started TRT, felt better, TRT did it. Three months is a short window. Perimenopause symptoms fluctuate naturally. Placebo response in hormone studies is well-documented and can be substantial. A 2013 trial in JAMA Internal Medicine (Kroenke et al.) found meaningful placebo effects in hormone-related symptom trials. None of this means TRT didn't help her. It means one person's three-month result is not a blueprint.

What should you actually know?

If you're a woman in perimenopause considering testosterone, here are the things this video will not tell you. First, testosterone for women is off-label in the US, so your prescriber should be explaining that explicitly and documenting it. Second, the Global Consensus Position Statement (Davis et al., 2019) recommends physiologic doses that keep blood levels in the normal female range, not male ranges. Third, delivery method matters: pellets, which are popular in telehealth settings, have less adjustability than gels or injections if levels go too high. Symptoms of excess testosterone in women include acne, hair loss, and voice changes, and some of those effects may not be fully reversible.

The creator's core message, that women deserve providers who take their symptoms seriously, is fair. The problem is that a three-month testimonial with no labs, no symptom tracking, and no comparison group is not evidence. It's a starting point for a conversation with your own doctor.